期刊文献+

重组丙型肝炎病毒核心蛋白的原核表达、纯化和抗体制备 被引量:1

Prokaryotic expression and purification of hepatitis C virus core protein(HCV-C)and preparation of polyclonal antibodies against HCV-C
下载PDF
导出
摘要 本文旨在获得纯化丙型肝炎病毒(HCV)核心蛋白(HCV-C)及抗HCV-C多克隆抗体,为深入研究HCV-C与肝细胞相互作用的分子机制奠定基础。首先以HCV1b亚型HC-J4-91全基因组质粒为模板,聚合酶链反应(PCR)扩增HCV-C基因,构建重组质粒pQE31-HCV-C。融合蛋白经原核表达、纯化后,免疫BALB/c小鼠,制备抗HCV-C多克隆抗体。利用酶联免疫吸附试验(ELISA)检测抗体效价,蛋白免疫印迹(Westernblot)和间接免疫荧光染色鉴定抗体特异性。结果显示,表达HCV-C的原核表达质粒pQE31-HCV-C构建正确,获得相对分子质量约22000的纯化融合蛋白。ELISA检测重组蛋白免疫小鼠的抗血清效价达1:12800。结果显示,自制的抗HCV-C多克隆抗体能特异性识别HCV-C。本研究获得了纯度较好、原核表达的HCV-C,并成功制备了抗HCV-C多克隆抗体,为深入研究HCV-C的致病机制提供了有实用价值的研究工具。 To investigate the interaction between hepatitis C virus core protein(HCV-C)and liver cells,purified HCV-C was obtained and polyclonal antibodies against HCV-C were prepared in the present study.The plasmid containing HC-J4-91whole genome of HCV1bsubtype was used as the template and the HCVC gene was TA-cloned by polymerase chain reaction(PCR).The prokaryotic expression plasmid containing 6×His and HCV-C gene was constructed and named as pQE31-HCV-C.After expression in Escherichia coli and purification,the recombinant HCV-C was used to immunize BALB/c mice to obtain the antiserum.The titer and specificity of the antibody were determined by enzyme-linked immunosorbent assay(ELISA),Western blot and indirect immunofluorescence staining.The results demonstrated that the prokaryotic expression plasmid pQE31-HCV-C expressing a 22 000fusion protein was successfully constructed.ELISA showed that antiserum against HCV-C from immunized mice had high antibody level,with titer at 1:12 800.Immunofluorescence staining and Western blot indicated that the antibody had good specificity and could recognize natural and unnatural HCV-C.It is concluded that the purified HCV-C protein and anti-HCV-C polyclonal antibodies obtained in this study might be useful for studying the molecular interaction mechanism between HCV-C and liver cells.
出处 《微生物与感染》 2010年第3期140-145,共6页 Journal of Microbes and Infections
基金 国家自然科学基金(30872227) 国家"十一五"科技重大专项(2009ZX10004-305)
关键词 丙型肝炎病毒 核心蛋白 原核表达 抗体制备 Hepatitis C virus Core protein Prokaryotic expression Antibody preparation
  • 相关文献

参考文献13

  • 1Bartosch B,Thimme R,Hubert E,Blum,Zoulim F.Hepatitis C virus-induced hepatocarcinogenesis[J].J Hepatol,2009,51(4):810-820.
  • 2Irshad M,Dhar I.Hepatitis C virus core protein:an update on its molecular biology,cellular functions and clinical implications[J].Med Princ Pract,2006,15(6):405-416.
  • 3Tran G.The role of hepatitis C virus in the pathogenesis of hepatocellular carcinoma[J].Res Horiz,2008,1 (2):167-175.
  • 4Klein K C,Delloss S R,Lingappa J R.Identification of residues in the hepatitis C virus core protein that are critical for capsid assembly in a cell free system[J].J Virol,2005,79(11):6814-6826.
  • 5Dhumeaux D.Steatosis,fibrosis and hepatitis C virus infection[J].Arab J Gastroenterol,2010,10(4 Suppl):S30-S31.
  • 6Saito K,Meyer K,Warner R,Basu A,Ray RB,Ray R.Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein[J].J Virol,2006,80(9):4372-4379.
  • 7Spaziani A,Alisi A,Sanna D,Balsano C.Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1[J].J Biol Chem,2006,281(16):10983-10989.
  • 8Mori Y,Moriishi K,Matsuura Y.Hepatitis C virus core protein:Its coordinate roles with PA28 gamma in metabolic abnormality and carcinogenicity in the liver[J].Int J Biochem Cell Biol,2008,40(8):1437-1442.
  • 9Herzer K,Weyer S,Krammer PH,Galle PR,Hofmann TG.Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells[J].Cancer Res,2005,65(23):10830-10837.
  • 10Battaglia S,Benzoubir N,Nobilet S,Charneau P,Samuel D,Zignego AL,Atfi A,Christian B,Bourgeade MF.Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition[J].PLoS ONE,2009,4(2):e4355.

同被引文献11

  • 1Gao N, Chen W, Zheng Q, et al. Co expression of Japa- nese encephalitis virus prM-E-NS1 antigen with granulo- cyte-macrophage colony-stimulating factor enhances hu- moral and anti-virus immunity after DNA vaccination [J]. ImmunolLett, 2010, 129(1) :23-31.
  • 2Richard A Nash, Friedrich Schuening, Frederick Appel- baum, et al. Molecular cloning and in vivo evaluation of canine granulocyte-maerophage colony-stimulating factor [J]. Blood, 1991, 78(4) :930-937.
  • 3O'Mahony D S, Pham U, Iyer R, et al. Differential con- stitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes,and macrophages [J]. Int J Med Sci, 2008,5(1):1-8.
  • 4G Dranoff, E Jaffee, A Lazenby, P Golumbek, et al. Vaccination with irradiated tumor cells engineered to se- crete routine granuloeyte-maerophage colony-stimulating factor stimulates potent, specific, and long-lasting anti- tumor immunity [J]. Proc Natl Acad Sci, 1993, 90(8) : 3539 -3543.
  • 5Pisa P, Halapi E, Pisa E K et al. Selective expression of interleukin-10, interferon-a, and granulocyte macro- phage-stimulating factor in ovarian cancer biopsies [J]. Proc Natl Acad Sci USA, 1992, 89: 7708-7712.
  • 6Lang S H, Miller W R, Duncan W, Habib F K. Pro- duction and response of human prostate cancer cell lines to granulocyte macrophage-eolony stimulating factor[J]. Int J Cancer, 1994, 59: 235-241.
  • 7Cao H, Ver96 V, Baron C, et al. In vitro generation of dendritic cells from human blood monocytes in experi- mental conditions compatible for in vivo cell therapy [J]. J Hematother Stem Cell Res, 2000, 9(2): 183- 194.
  • 8Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells [J]. Annu Rev Immunol, 2000, 18: 767-811.
  • 9Kusakabe KIKO, Xin H, Katoh K, et al. The timing of GM-CSF expression plasmid administration influences the Thl/Th2 response induced by an HIV-l-specific DNA vaccine [J]. Immunol, 2000, 164:3102-3111.
  • 10Barouch D H, Santra S, Racz K T, et al. Potent CD4 + T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gpl20 and GMCSF [J]. Im- munol, 2002, 168:562-568.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部